Unified Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.32M Sell
20,984
-735
-3% -$71K 2.04% 6
2026
Q2
$1.7M Buy
21,719
+400
+2% +$27.3K 1.57% 17
2026
Q1
$1.38M Sell
21,319
-295
-1% -$20.8K 1.41% 17
2025
Q4
$1.45M Sell
21,614
-270
-1% -$18.2K 1.46% 16
2025
Q3
$1.6M Sell
21,884
-310
-1% -$20.6K 1.6% 14
2025
Q2
$1.15M Buy
22,194
+847
+4% +$48.2K 1.24% 20
2025
Q1
$1.36M Buy
21,347
+2,622
+14% +$152K 1.61% 15
2024
Q4
$895K Buy
+18,725
New +$960K 1.02% 30

Other funds holding HALO

Unified Investment Management's HALO Position: Q3 2026 in Review

Unified Investment Management reduced its Halozyme (HALO) stake by 3.4% in Q3 2026, selling an estimated $71K and leaving 20,984 shares worth $2.32M. The position accounts for 2.04% of the portfolio, ranked #6.

Unified Investment Management first reported a position in HALO in Q4 2024 and has held it in 8 quarters since. 85 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Unified Investment Management held 20,984 shares of Halozyme worth $2.32M as of Q3 2026.
  • Unified Investment Management sold 735 Halozyme shares in Q3 2026, an estimated $71K.
  • Halozyme made up 2.04% of Unified Investment Management's portfolio in Q3 2026, its #6 holding.
  • Unified Investment Management first reported a position in Halozyme in Q4 2024 and has held it in 8 quarters since.
  • 85 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Unified Investment Management's 13F filing for Q3 2026, filed 14 Oct 2026.